7th Microbiome Movement – Drug Development Summit

The 7th Microbiome Movement – Drug Development Summit returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event – now in its 7th year – is evolving to showcase these new studies. With this progress however comes new challenges, and we’re excited to once again be uniting over 300 microbiome pioneers to work towards overcoming these challenges and moving the whole industry closer to commercial approval.

Continuing to unite the most forward-thinking researchers from the biopharmaceutical industry, our unrivaled program will uncover microbiome functionality and mechanisms, decipher translation issues and advance clinical development, overcome the key GMP manufacturing and scale-up challenges, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes.

This event is the most comprehensive forum for microbiome drug developers and the perfect opportunity for the industry to take a collaborative approach to close the clinical gap, discover the next generation of microbiome-based therapeutics, and establish new partnerships to accelerate your research.

To know more visit: https://bit.ly/3hss4dD